Live Breaking News & Updates on Treatment With Anti Coronavirus Immunoglobulin

Stay updated with breaking news from Treatment with anti coronavirus immunoglobulin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

CoVIg-19 Plasma Alliance Announces Topline Results from NIH-Sponsored Clinical Trial of Investigational COVID-19 Hyperimmune Globulin Medicine


CoVIg-19 Plasma Alliance
Saturday, April 3, 2021 2:00PM IST (8:30AM GMT)
 
Osaka, Japan & King of Prussia, Pa., United States:
  
Phase 3 Inpatient Treatment With Anti-Coronavirus Immunoglobulin (ITAC) Clinical Trial Sponsored and Funded by the National Institute of Allergy and Infectious Diseases (NIAID), Part of the National Institutes of Health (NIH), Did Not Meet Its Endpoints to Show Efficacy in Adults Hospitalized With COVID-19
The CoVIg-19 Plasma Alliance today announced that the Phase 3 Inpatient Treatment with Anti-Coronavirus Immunoglobulin (ITAC) clinical trial sponsored and funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), did not meet its endpoints. No serious safety signals were raised in the trial. ....

United States , Julie Kim , Plasma Alliance , Head Of Research , National Institutes Of Health , National Institute Of Allergy , Melinda Gates Foundation , National Bioproducts Institute , Part Of The National Institutes Health , Uber Health , Alliance As Covig , Treatment With Anti Coronavirus Immunoglobulin , Clinical Trial Sponsored , National Institute , Infectious Diseases , National Institutes , Did Not Meet Its Endpoints , Show Efficacy , Adults Hospitalized With , Anti Coronavirus Immunoglobulin , Bill Mezzanotte , Executive Vice President , Chief Medical Officer , Plasma Derived Therapies Business Unit , Emergent Biosolutions , Biopharma Plasma ,